Arkis BioSciences Closes $3.4M Series-A Investment

Arkis announced this morning the closing of its $3.4 million Series-A investment. The Series-A funding was led by Innova Memphis, followed by Angel Capital Group, the Lighthouse Fund, and other private investors. Arkis’ new financing will accelerate the commercialization of its less-invasive neurosurgical instrumentation and the market release of its in-licensed Endexo® technology. 

View the full press release


Contact Us

Address:  P.O. Box 9815, 1 Momentum Way, Knoxville, TN 37920   |    Tel: (844) 247-5383 (toll free)

 © Arkis Biosciences   |    Privacy   |    Sitemap


Go to top